Artwork

内容由Jörn "Joe" Menninger提供。所有播客内容(包括剧集、图形和播客描述)均由 Jörn "Joe" Menninger 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Innovating Epilepsy Treatment: How PRECISIS is Transforming Healthcare Startups with the EASEE System

32:31
 
分享
 

Manage episode 450104902 series 3419552
内容由Jörn "Joe" Menninger提供。所有播客内容(包括剧集、图形和播客描述)均由 Jörn "Joe" Menninger 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Join Startuprad.io, the authority on the DACH region’s vibrant startup ecosystem, for an exclusive interview with Karl Stoklosa, CEO of PRECISIS, a healthcare startup revolutionizing epilepsy treatment through cutting-edge technology. In this episode, we explore how PRECISIS is leveraging its groundbreaking EASI System—the world’s first minimally invasive brain pacemaker—to improve the lives of epilepsy patients worldwide.

What You’ll Learn in This Episode:

  1. Karl Stoklosa’s Leadership Journey: From an Executive MBA at the University of Chicago Booth School to leading a disruptive healthcare startup, Karl shares insights into his 20+ years of experience in the medical device industry, spanning roles in neuromodulation, cardiac rhythm management, and global healthcare marketing.

  2. The Global Epilepsy Challenge: With 50 million epilepsy patients worldwide and 30% classified as drug-resistant, the need for innovative solutions is critical. Discover how PRECISIS is addressing this gap with the EASI System, providing safer, more effective alternatives to invasive surgeries and medications.

  3. The EASI System’s Impact: Learn about this state-of-the-art neuromodulation device, its minimally invasive design, and its ability to reduce seizures by 50% or more for most patients. With features like manual stimulation for oncoming seizures and MRI compatibility, the EASI System sets a new standard in epilepsy care.

  4. PRECISIS’ European Success: PRECISIS has achieved market approval in key European countries, including Germany, Austria, Switzerland, the UK, and Portugal, and is scaling its commercial operations.

  5. Expansion into the U.S. Market: With FDA breakthrough designation, PRECISIS is preparing for clinical trials in the U.S., showcasing its ambition to become a global leader in medical device innovation.

Call to Action:

Love what you hear? Share this episode, leave us a review, and subscribe to Startuprad.io to stay updated on the latest from the startup ecosystem in Germany, Austria, Switzerland, and beyond!

Explore:

Special Offer: Startuprad.io listeners can create two free SEO-optimized blog posts per month with ModernIQs.com. Sign up now to claim this exclusive deal!

Interested in Working with us? Have a look here: https://www.passionfroot.me/startupradio
  continue reading

180集单集

Artwork
icon分享
 
Manage episode 450104902 series 3419552
内容由Jörn "Joe" Menninger提供。所有播客内容(包括剧集、图形和播客描述)均由 Jörn "Joe" Menninger 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Join Startuprad.io, the authority on the DACH region’s vibrant startup ecosystem, for an exclusive interview with Karl Stoklosa, CEO of PRECISIS, a healthcare startup revolutionizing epilepsy treatment through cutting-edge technology. In this episode, we explore how PRECISIS is leveraging its groundbreaking EASI System—the world’s first minimally invasive brain pacemaker—to improve the lives of epilepsy patients worldwide.

What You’ll Learn in This Episode:

  1. Karl Stoklosa’s Leadership Journey: From an Executive MBA at the University of Chicago Booth School to leading a disruptive healthcare startup, Karl shares insights into his 20+ years of experience in the medical device industry, spanning roles in neuromodulation, cardiac rhythm management, and global healthcare marketing.

  2. The Global Epilepsy Challenge: With 50 million epilepsy patients worldwide and 30% classified as drug-resistant, the need for innovative solutions is critical. Discover how PRECISIS is addressing this gap with the EASI System, providing safer, more effective alternatives to invasive surgeries and medications.

  3. The EASI System’s Impact: Learn about this state-of-the-art neuromodulation device, its minimally invasive design, and its ability to reduce seizures by 50% or more for most patients. With features like manual stimulation for oncoming seizures and MRI compatibility, the EASI System sets a new standard in epilepsy care.

  4. PRECISIS’ European Success: PRECISIS has achieved market approval in key European countries, including Germany, Austria, Switzerland, the UK, and Portugal, and is scaling its commercial operations.

  5. Expansion into the U.S. Market: With FDA breakthrough designation, PRECISIS is preparing for clinical trials in the U.S., showcasing its ambition to become a global leader in medical device innovation.

Call to Action:

Love what you hear? Share this episode, leave us a review, and subscribe to Startuprad.io to stay updated on the latest from the startup ecosystem in Germany, Austria, Switzerland, and beyond!

Explore:

Special Offer: Startuprad.io listeners can create two free SEO-optimized blog posts per month with ModernIQs.com. Sign up now to claim this exclusive deal!

Interested in Working with us? Have a look here: https://www.passionfroot.me/startupradio
  continue reading

180集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放